Literature DB >> 3197736

Maternal phenylketonuria: successful outcome in four pregnancies treated prior to conception.

B C Lynch1, D B Pitt, T G Maddison, J E Wraith, D M Danks.   

Abstract

The management of four pregnancies in two phenylketonuric women is described. A successful outcome in these pregnancies is ascribed to the initiation of treatment prior to conception and the maintenance of tight control with serum phenylalanine between 100 and 400 mumol/l throughout the gestation period. A trial of diet is desirable before a decision is made about pregnancy and before contraception is ceased. Close contact must be maintained with female phenylketonurics throughout their reproductive life to ensure that this process is followed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197736     DOI: 10.1007/bf00441820

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Maternal phenylketonuria.

Authors:  R Koch; E G Friedman; E Wenz; K Jew; C Crowley; G Donnell
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 2.  Transport of amino acids in the placenta.

Authors:  D L Yudilevich; J H Sweiry
Journal:  Biochim Biophys Acta       Date:  1985-09-09

3.  The metabolic and endocrine milieu of the human fetus and mother at 18-21 weeks of gestation. I. Plasma amino acid concentrations.

Authors:  G Soltesz; D Harris; I Z Mackenzie; A Aynsley-Green
Journal:  Pediatr Res       Date:  1985-01       Impact factor: 3.756

4.  Outcome of pregnancy in a phenylketonuric mother after low phenylalanine diet introduced from the ninth week of pregnancy.

Authors:  D C Davidson; D M Isherwood; J T Ireland; P G Rae
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

5.  Maternal phenylketonuria: comparison of two treated full term pregnancies.

Authors:  R P Soeters; R C Sengers; P W van Dongen; J M Trijbels; T K Eskes
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

6.  Management of maternal phenylketonuria: an emerging clinical problem.

Authors:  G M Komrower; I B Sardharwalla; J M Coutts; D Ingham
Journal:  Br Med J       Date:  1979-05-26

7.  New England Maternal PKU Project: prospective study of untreated and treated pregnancies and their outcomes.

Authors:  F J Rohr; L B Doherty; S E Waisbren; I V Bailey; M G Ampola; B Benacerraf; H L Levy
Journal:  J Pediatr       Date:  1987-03       Impact factor: 4.406

8.  Timing of strict diet in relation to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHSS Phenylketonuria Register.

Authors:  E Drogari; I Smith; M Beasley; J K Lloyd
Journal:  Lancet       Date:  1987-10-24       Impact factor: 79.321

9.  Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

Authors:  R R Lenke; H L Levy
Journal:  N Engl J Med       Date:  1980-11-20       Impact factor: 91.245

10.  Problems related to diet management of maternal phenylketonuria.

Authors:  P B Acosta; S Stepnick-Gropper
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

  10 in total
  2 in total

1.  Cognitive development in offspring of untreated and preconceptionally treated maternal phenylketonuria.

Authors:  F Güttler; H Lou; J Andresen; K Kok; I Mikkelsen; K B Nielsen; J B Nielsen
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Neonatal neurological assessment of offspring in maternal phenylketonuria.

Authors:  S E Waisbren; P Chang; H L Levy; H Shifrin; E Allred; C Azen; F de la Cruz; W Hanley; R Koch; R Matalon; B Rouse
Journal:  J Inherit Metab Dis       Date:  1998-02       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.